Browsing by 저자 : 윤신교
전체 결과 22건 중 1-22 번을 표시중입니다.
- 1 Article Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer 공경엽 ; 김덕훈 ; 김상위 ; et al 2020
- 2 Article Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma 김형렬 ; 안보경 ; 윤신교 ; et al 2021
- 3 Article Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease 김상위 ; 김수한 ; 김우성 ; et al 2020
- 4 Article Comparison of RECIST 1.1 and irecist in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis 박효정 ; 김건하 ; 김경원 ; et al 2021
- 5 Article Comparison of RECIST 1.1 and irecist in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis 박효정 ; 김건하 ; 김경원 ; et al 2021
- 6 Article Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis 박효정 ; 김경원 ; 원상은 ; et al 2021
- 7 Article Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study 김상위 ; 김우성 ; 윤신교 ; et al 2021
- 8 Article Exploring the resistance mechanisms of second-line osimertinib and their prognostic implications using next-generation sequencing in patients with non-small-cell lung cancer 김덕훈 ; 김상위 ; 윤신교 ; et al 2021
- 9 Article Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16) 박인근 ; 김봉석 ; 김희준 ; et al 2020
- 10 Article Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients 김미소 ; 김범석 ; 박권오 ; et al 2021
- 11 Article How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers 구하영 ; 김규표 ; 김선영 ; et al 2020
- 12 Article Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors 이재련 ; 황인환 ; 박인근 ; et al 2020
- 13 Article Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors 원상은 ; 박효정 ; 변상일 ; et al 2020
- 14 Article Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis 박효정 ; 김경원 ; 표준희 ; et al 2020
-
15
dissertation
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer
윤신교
2022
- 16 Article Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung 김상위 ; 김우성 ; 윤신교 ; et al 2021
- 17 Article Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis 김상위 ; 김우성 ; 윤신교 ; et al 2020
- 18 Article Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma 김정곤 ; 박계진 ; 박범우 ; et al 2020
- 19 Article Real-world data analysis of patients with cancer of unknown primary 강소라 ; 김규표 ; 김정은 ; et al 2021
- 20 Article Real-world utility of next-generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma 김상위 ; 김좌훈 ; 윤신교 ; et al 2021
- 21 Article Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer 김권일 ; 김상위 ; 윤신교 ; et al 2021
- 22 Article Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5 김좌훈 ; 김형돈 ; 박인근 ; et al 2021
1